Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III...
9 insider purchases on record · latest filing 2023-08-09.
Insiders have also filed 2 sale transactions at VTGN.